Bota Bio, a Nest.Bio alumni, recently announced that they raised $100 million in Series B financing. Their team has been committed to finding solutions in biomanufacturing that are not only sustainable for the environment but can also sustain production throughout a pandemic. Bota Bio offers a broad spectrum of solutions for the manufacturing process including technical support, data analysis, and high-quality products. They developed the Bota Freeway which uses AI to efficiently produce strains and enzymes with high stability that can withstand conditions of the manufacturing environment. Bota aims to use the funds for its global expansion while improving its platforms and production pipelines.
Learn more about Bota Bio here...
